SCHEMBL5155693

SCHEMBL5155693

CCC(C)[SiH2]OS(=O)(=O)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6686763 0.81
SCHEMBL16469194 0.78 F2 (0.30)
SCHEMBL4435018 0.71
SCHEMBL14139030 0.70
SCHEMBL10364856 0.70
SCHEMBL14793049 0.70
SCHEMBL28408544 0.68 F2 (0.31)
SCHEMBL6552562 0.68 EPHX1 (0.31)
SCHEMBL2904316 0.67 CA1 (0.38)
SCHEMBL14779384 0.67 CA1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740620-A1 PREPARATION PROCESS OF OLIGOGLYCOSAMINOGLYCAN, AND REDUCING END GLUCURONIC ACID TYPE OLIGOCHONDROITIN SULFATE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME TAISHO PHARMACEUTICAL CO., LTD (JP) 2007-01-10 EP disclosed
WO-2005092931-A1 PREPARATION PROCESS OF OLIGOGLYCOSAMINOGLYCAN, AND REDUCING END GLUCURONIC ACID TYPE OLIGOCHONDROITIN SULFATE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME TAISHO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 WO disclosed